nach oben

Erschienen in:

29.10.2018 | Case Report - Pituitaries

Growth hormone-secreting pituitary macroadenoma presenting concurrently with non-Hodgkin’s lymphoma and responding to doxorubicin treatment: case report and review of the literature

verfasst von: Gregory P. Lekovic, Asheesh Batra, Zachary R. Barnard, Eric P. Wilkinson, Richard Balena, Sheri Palejwala, Garni Barkhoudarian

Erschienen in: Acta Neurochirurgica | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Abstract

We present a case report of a patient who presented with nausea and vomiting, as well as acromegalic features. Following testing, a pituitary adenoma and mediastinal non-Hodgkin’s lymphoma were diagnosed. Following two cycles of R-CHOP chemotherapy, imaging showed significant decrease in size of the sellar tumor. Following resection of tumor, both frozen and permanent section revealed only necrotic material. Further research into the potential utility of doxorubicin for the treatment of recurrent or refractory pituitary adenomas may be warranted.

Attanasio R, Orlandi P, Dallabonzana D, Lodrini A, Ferrari M, Maccagnano E, Verde G, Cozzi R, Liuzzi A, Chiodini PG (1991) Doxorubicin for acromegaly: a case report. J Endocrinol Investig 14:493–497CrossRef

Aydogan BI, Unluturk U, Emral R, Gullu S (2017) Course of aggressive somatotroph, corticotroph and mammotroph tumors under temozolomide; report of three cases and review of the literature. Turk Neurosurg. https://doi.org/10.5137/1019-5149.JTN.20216-17.1

Colao A, Ferone D, Marzullo P, Cappabianca P, Cirillo S, Boerlin V, Lancranjan I, Lombardi G (2001) Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly. J Clin Endocrinol Metab 86:2779–2786. https://doi.org/10.1210/jcem.86.6.75564 CrossRefPubMed

Freda PU (2002) Somatostatin analogs in acromegaly. J Clin Enocrinol Metab 87:3013–3018. https://doi.org/10.1210/jcem.87.7.8665 CrossRef

Kasperlik-Zaluska AA, Wislawski J, Kaniewska J, Zborzil J, Frankiewicz E, Zgliczynski S (1987) Cytostatics for acromegaly. Marked improvement in a patient with an invasive pituitary tumour. Acta Endocrinol 116:347–349CrossRef

Lancranjan I, Bruns C, Grass P, Jaquet P, Jervell J, Kendall-Taylor P, Lamberts SW, Marbach P, Orskov H, Pagani G, Sheppard M, Simionescu L (1996) Sandostatin LAR: a promising therapeutic tool in the management of acromegalic patients. Metabolism 45:67–71CrossRef

Liu X, Ma S, Dai C, Cai F, Yao Y, Yang Y, Feng M, Deng K, Li G, Ma W, Xin B, Lian W, Xiang G, Zhang B, Wang R (2013) Antiproliferative, antiinvasive, and proapoptotic activity of folate receptor alpha-targeted liposomal doxorubicin in nonfunctional pituitary adenoma cells. Endocrinology 154:1414–1423CrossRef

Ravindra VM, Raheja A, Corn H, Driscoll M, Welt C, Simmons DL, Couldwell WT (2017) Primary pituitary diffuse large B-cell lymphoma with somatotroph hyperplasia and acromegaly: case report. J Neurosurg 126:1725–1730CrossRef

Roberts BK, Ouyang DL, Lad SP, Chang SD, GRt H, Adler JR Jr, Soltys SG, Gibbs IC, Remedios L, Katznelson L (2007) Efficacy and safety of CyberKnife radiosurgery for acromegaly. Pituitary 10:19–25CrossRef

10.

Tritos NA, Biller BM (2017) Pegvisomant: a growth hormone receptor antagonist used in the treatment of acromegaly. Pituitary 20:129–135CrossRef

Titel: Growth hormone-secreting pituitary macroadenoma presenting concurrently with non-Hodgkin’s lymphoma and responding to doxorubicin treatment: case report and review of the literature
verfasst von: Gregory P. Lekovic
Asheesh Batra
Zachary R. Barnard
Eric P. Wilkinson
Richard Balena
Sheri Palejwala
Garni Barkhoudarian
Publikationsdatum: 29.10.2018
Verlag: Springer Vienna
Erschienen in: Acta Neurochirurgica / Ausgabe 12/2018
Print ISSN: 0001-6268
Elektronische ISSN: 0942-0940
DOI: https://doi.org/10.1007/s00701-018-3714-6

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

18.04.2024 | Arterielle Hypertonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Growth hormone-secreting pituitary macroadenoma presenting concurrently with non-Hodgkin’s lymphoma and responding to doxorubicin treatment: case report and review of the literature

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Manche Gestagene können das Risiko für Meningeome erhöhen

Parkinson: Größere Studie bestätigt Genauigkeit von Hauttest

Update Neurologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2018

Hereditary clear cell meningiomas in a single family: three-cases report

How I do it: percutaneous transforaminal endoscopic discectomy for lumbar disk herniation

Eight-year survival of a recurrent glioblastoma patient treated with molecularly tailored therapy: a case report

Superficial radial intraneural ganglion cysts at the wrist

Incidence and clinical significance of postoperative delirium after brain tumor surgery

Ruptured intranidal aneurysm of an arteriovenous malformation diagnosed by delay alternating with nutation for tailored excitation (DANTE)–prepared contrast-enhanced magnetic resonance imaging

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Manche Gestagene können das Risiko für Meningeome erhöhen

Parkinson: Größere Studie bestätigt Genauigkeit von Hauttest

Update Neurologie